PET imaging of medullary thyroid carcinoma in MEN2A transgenic mice using 6-[18F]F-L-DOPA

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 37, Issue 1, 2010, Pages 58-66

  Pestourie, Carine ^a,b   Thézé, Benoît ^a,b   Kuhnast, Bertrand ^a   Le Helleix, Stéphane ^a   Gombert, Karine ^a,b   Dollé, Frédéric ^a   Tavitian, Bertrand ^a,b   Ducongé, Frédéric ^a,b  

^a SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

^b INSERM   (France)

Author keywords

6 18F F L DOPA; Medullary thyroid carcinoma; MEN2A transgenic mice; Small animal PET imaging

Indexed keywords

6 FLUORODOPA F 18; FLUCIS; FLUORODEOXYGLUCOSE F 18; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPSY; DIAGNOSTIC VALUE; HISTOPATHOLOGY; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; SIPPLE SYNDROME; THYROID MEDULLARY CARCINOMA; TRANSGENIC MOUSE; TUMOR VOLUME;

EID: 72949085037     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-009-1208-8     Document Type: Article

References (25)

1. JR Hansford LM Mulligan 2000 Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis J Med Genet 37 11 817 827 10.1136/jmg.37.11.817 1:CAS:528:DC%2BD3cXos1Oktb8%3D 11073534
2. SJ Marx 2005 Molecular genetics of multiple endocrine neoplasia types 1 and 2 Nat Rev Cancer 5 5 367 375 10.1038/nrc1610 1:CAS:528:DC%2BD2MXjslertbo%3D 15864278 (Pubitemid 40637828)
3. F Marini A Falchetti F Del Monte S Carbonell Sala I Tognarini E Luzi ML Brandi 2006 Multiple endocrine neoplasia type 2 Orphanet J Rare Dis 1 45 10.1186/1750-1172-1-45 17105651
4. S Ezzat P Huang A Dackiw SL Asa 2005 Dual inhibition of RET and FGFR4 restrains medullary thyroid cancer cell growth Clin Cancer Res 11 3 1336 1341 1:CAS:528:DC%2BD2MXht1ynur4%3D 15709206
5. G Petrangolini G Cuccuru C Lanzi M Tortoreto S Belluco G Pratesi G Cassinelli F Zunino 2006 Apoptotic cell death induction and angiogenesis inhibition in large established medullary thyroid carcinoma xenografts by Ret inhibitor RPI-1 Biochem Pharmacol 72 4 405 414 10.1016/j.bcp.2006.05.002 1:CAS:528:DC%2BD28XntFWktbc%3D 16756963 (Pubitemid 44061744)
6. KA Knostman SM Jhiang CC Capen 2007 Genetic alterations in thyroid cancer: the role of mouse models Vet Pathol 44 1 1 14 10.1354/vp.44-1-1 1:CAS:528:DC%2BD2sXhtlSms7Y%3D 17197619 (Pubitemid 46074958)
7. FM Michiels S Chappuis B Caillou A Pasini M Talbot R Monier GM Lenoir J Feunteun M Billaud 1997 Development of medullary thyroid carcinoma in transgenic mice expressing the RET protooncogene altered by a multiple endocrine neoplasia type 2A mutation Proc Natl Acad Sci U S A 94 7 3330 3335 10.1073/pnas.94.7.3330 1:CAS:528:DyaK2sXisVKnsr4%3D 9096393 (Pubitemid 27157311)
8. JK Willmann N van Bruggen LM Dinkelborg SS Gambhir 2008 Molecular imaging in drug development Nat Rev Drug Discov 7 7 591 607 10.1038/nrd2290 1:CAS:528:DC%2BD1cXnvFShsbs%3D 18591980 (Pubitemid 351927724)
9. B Riemann KP Schäfers O Schober M Schäfers 2008 Small animal PET in preclinical studies: opportunities and challenges Q J Nucl Med Mol Imaging 52 3 215 221 1:STN:280:DC%2BD1czotF2qtA%3D%3D 18551093
10. A Sundin U Garske H Orlefors 2007 Nuclear imaging of neuroendocrine tumours Best Pract Res Clin Endocrinol Metab 21 1 69 85 10.1016/j.beem.2006.12. 003 1:CAS:528:DC%2BD2sXjsVSqt7g%3D 17382266 (Pubitemid 46421900)
11. V Rufini G Treglia G Perotti L Leccisotti ML Calcagni D Rubello 2008 Role of PET in medullary thyroid carcinoma Minerva Endocrinol 33 2 67 73 1:STN:280:DC%2BD1c3lt1Wjsw%3D%3D 18388854
12. KP Koopmans JW de Groot JT Plukker EG de Vries IP Kema WJ Sluiter PL Jager TP Links 2008 18F-dihydroxyphenylalanine PET in patients with biochemical evidence of medullary thyroid cancer: relation to tumor differentiation J Nucl Med 49 4 524 531 10.2967/jnumed.107.047720 1:CAS:528:DC%2BD1cXltl2gtLs%3D 18375923
13. KP Koopmans EG de Vries IP Kema PH Elsinga OC Neels WJ Sluiter AN van der Horst-Schrivers PL Jager 2006 Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study Lancet Oncol 7 9 728 734 10.1016/S1470-2045(06)70801-4 1:CAS:528:DC%2BD28Xptlyrsr4%3D 16945767 (Pubitemid 44283659)
14. HJ Timmers M Hadi JA Carrasquillo CC Chen L Martiniova M Whatley A Ling G Eisenhofer KT Adams K Pacak 2007 The effects of carbidopa on uptake of 6-18F-Fluoro-L-DOPA in PET of pheochromocytoma and extraadrenal abdominal paraganglioma J Nucl Med 48 10 1599 1606 10.2967/jnumed.107.042721 1:CAS:528:DC%2BD2sXht1GlurjL 17873132 (Pubitemid 47572706)
15. PL Jager R Chirakal CJ Marriott AH Brouwers KP Koopmans KY Gulenchyn 2008 6-L-18F-fluorodihydroxyphenylalanine PET in neuroendocrine tumors: basic aspects and emerging clinical applications J Nucl Med 49 4 573 586 10.2967/jnumed.107.045708 1:CAS:528:DC%2BD1cXltl2gtLg%3D 18344441
16. OC Neels KP Koopmans PL Jager L Vercauteren A van Waarde J Doorduin H Timmer-Bosscha AH Brouwers EG de Vries RA Dierckx IP Kema PH Elsinga 2008 Manipulation of [11C]-5-hydroxytryptophan and 6-[18F]fluoro-3,4-dihydroxy-L- phenylalanine accumulation in neuroendocrine tumor cells Cancer Res 68 17 7183 7190 10.1158/0008-5472.CAN-08-0095 1:CAS:528:DC%2BD1cXhtVCrs7fI 18757434
17. M Namavari A Bishop N Satyamurthy G Bida JR Barrio 1992 Regioselective radiofluorodestannylation with [18F]F2 and [18F]CH3COOF: a high yield synthesis of 6-[18F]Fluoro-L-dopa Int J Rad Appl Instrum A 43 8 989 996 10.1016/0883-2889(92)90217-3 1:CAS:528:DyaK38XmtFaktb8%3D 1330984
18. F Dollé S Demphel F Hinnen D Fournier F Vaufrey C Crouzel 1998 6-[18F]Fluoro-L-DOPA by radiofluorodestannylation: a short and simple synthesis of a new labelling precursor J Label Compd Radiopharm 41 105 114 10.1002/(SICI)1099-1344(199802)41:2<105::AID-JLCR65>3.0.CO;2-H (Pubitemid 28041242)
19. R Nickles M Daube T Ruth 1984 An 18O2 target for the production of [18F]F2 Int J Appl Radiat Isot 35 117 122 10.1016/0020-708X(84)90194-7 1:CAS:528:DyaL2cXhsVKqsbs%3D
20. Rasband W. ImageJ 1.39 f. National Institutes of Health, USA. http://rsb.info.nih.gov/ij/. Accessed May 2009
21. S Hoegerle C Altehoefer N Ghanem G Koehler CF Waller H Scheruebl E Moser E Nitzsche 2001 Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors Radiology 220 2 373 380 1:STN:280:DC%2BD3MvjtFWksA%3D%3D 11477239
22. SK Sharma M Ebadi 2005 Distribution kinetics of 18F-DOPA in weaver mutant mice Brain Res Mol Brain Res 139 1 23 30 10.1016/j.molbrainres.2005.05.018 1:CAS:528:DC%2BD2MXpslCgsrc%3D 15979197 (Pubitemid 41583586)
23. CJ Endres OT DeJesus H Uno DJ Doudet JR Nickles JE Holden 2004 Time profile of cerebral [18F]6-fluoro-L-DOPA metabolites in nonhuman primate: implications for the kinetics of therapeutic L-DOPA Front Biosci 9 505 512 10.2741/1224 1:CAS:528:DC%2BD2cXhtFCkt7g%3D 14766386
24. B Beuthien-Baumann A Strumpf J Zessin J Bredow J Kotzerke 2007 Diagnostic impact of PET with 18F-FDG, 18F-DOPA and 3-O-methyl-6-[18F]fluoro-DOPA in recurrent or metastatic medullary thyroid carcinoma Eur J Nucl Med Mol Imaging 34 10 1604 1609 10.1007/s00259-007-0425-2 1:CAS:528:DC%2BD2sXhtVOit7bL 17435996 (Pubitemid 47476914)
25. BM Pützer M Drosten 2004 The RET proto-oncogene: a potential target for molecular cancer therapy Trends Mol Med 10 7 351 357 10.1016/j.molmed.2004. 06.002 15242684 (Pubitemid 38881525)